MedTrace Logo

Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation

NCT02471664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2017-10-13

No results posted yet for this study

Summary

To evaluate safety and feasibility of Mitral Loop Cerclage(MLC) Annuloplasty with CSTV for repair of functional mitral regurgitation.

Conditions

Interventions

DEVICE

Mitral Loop Cerclage Annuloplasty

Sponsors & Collaborators

  • Tau-MEDICAL Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • June-Hong Kim, MD, Ph D · Pusan National University Yangsan Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-03-31
Completion
2016-07-31

Countries

  • United States
  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02471664 on ClinicalTrials.gov